Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

495
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
495

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Multi-Split-and-Mix Platform for a Variety of Targeted Protein Degradation.

ACS chemical biology·2025
Same author

Efficacy and Safety of Cold Atmospheric Plasma-Assisted Therapy for Herpes Zoster: A Randomized, Parallel, Positive-Controlled, Non-inferiority Multicenter Clinical Trial.

Dermatology and therapy·2025
Same author

The effect of circulating cytokines on the risk of systemic lupus erythematosus: Mendelian randomization and observational study.

Immunogenetics·2024
Same author

Shared genetic architecture highlights the bidirectional association between major depressive disorder and fracture risk.

General psychiatry·2024
Same author

A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy.

ACS chemical biology·2024
Same author

Deciphering the complex relationship between type 2 diabetes and fracture risk with both genetic and observational evidence.

eLife·2024

Related Experiment Video

Updated: Jun 28, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

374

Reevaluating Adiponectin's impact on obesity hypertension: a Chinese case-control study.

Ou Wu1,2, Xi Lu3, Jianhang Leng4

  • 1Shulan International Medical College, Zhejiang Shuren University, Hangzhou, Zhejiang, People's Republic of China.

BMC Cardiovascular Disorders
|April 13, 2024
PubMed
Summary

The "adiponectin paradox" in obesity-hypertension involves complex factors like metabolic homeostasis and adiponectin resistance. This study explored adiponectin

Keywords:
AdiponectinAlkaline phosphataseBlood pressureHypertensionObesityVisceral adiposity index

More Related Videos

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

488
Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
05:34

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice

Published on: January 24, 2025

934

Related Experiment Videos

Last Updated: Jun 28, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

374
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

488
Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
05:34

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice

Published on: January 24, 2025

934

Area of Science:

  • Cardiovascular Disease Research
  • Metabolic Syndrome Studies
  • Endocrinology and Metabolism

Background:

  • Obesity and hypertension are leading global risk factors for cardiovascular diseases.
  • Both conditions are linked to chronic inflammation, influenced by adipokines like adiponectin.
  • The
  • adiponectin paradox,
  • where high adiponectin levels are paradoxically associated with certain conditions, requires clarification in obesity-associated hypertension.

Purpose of the Study:

  • To investigate the multifaceted role of adiponectin in obesity-associated hypertension.
  • To analyze the impact of adiponectin on blood pressure, inflammation, and metabolic function in Chinese adults.
  • To elucidate the mechanisms underlying the
  • adiponectin paradox
  • in the context of obesity and hypertension.

Main Methods:

  • A case-control study involving 153 Chinese adults across four characteristic groups.
  • Measurement of serum adiponectin levels using ELISA.
  • Collection of clinical data including waist circumference, BMI, blood pressure, and laboratory markers, analyzed using SPSS.

Main Results:

  • Serum adiponectin levels were significantly higher in a normal healthy group compared to a newly diagnosed obesity group, negatively correlating with visceral adiposity index.
  • Multiple linear regression identified gender, serum albumin, alanine aminotransferase, and HDL cholesterol as independent correlates of serum adiponectin.
  • Age and HDL cholesterol were significant independent correlates for systolic blood pressure, while alkaline phosphatase correlated with diastolic blood pressure.

Conclusions:

  • Adiponectin's role in obesity-hypertension is complex, influenced by systemic metabolic homeostasis.
  • Compensatory effects, adiponectin resistance, and impaired clearance contribute to the observed
  • adiponectin paradox
  • in obesity-related hypertension.
  • Kidney and liver function may play a role in adiponectin clearance and the manifestation of this paradox.